384 related articles for article (PubMed ID: 19150871)
21. Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS).
Barba-Romero MÁ; Rivera-Gallego A; Pintos-Morell G;
Int J Clin Pract; 2011 Aug; 65(8):903-10. PubMed ID: 21679285
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Cerebral Microbleeds in Patients with Fabry Disease.
Kono Y; Wakabayashi T; Kobayashi M; Ohashi T; Eto Y; Ida H; Iguchi Y
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1320-5. PubMed ID: 26987491
[TBL] [Abstract][Full Text] [Related]
23. Renal involvement in Anderson-Fabry disease.
Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F
J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774
[TBL] [Abstract][Full Text] [Related]
24. Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry.
Politei JM; Cabrera G; Amartino H; Valdez R; Masllorens F; Ripeau D; Antongiovanni N; Soliani A; Luna P; Cedrolla M; Fernandez S; Fainboim A
Int J Clin Pract; 2013 Jan; 67(1):66-72. PubMed ID: 23241050
[TBL] [Abstract][Full Text] [Related]
25. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
[TBL] [Abstract][Full Text] [Related]
26. Natural history of the cerebrovascular complications of Fabry disease.
Mehta A; Ginsberg L;
Acta Paediatr Suppl; 2005 Mar; 94(447):24-7; discussion 9-10. PubMed ID: 15895708
[TBL] [Abstract][Full Text] [Related]
27. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
[TBL] [Abstract][Full Text] [Related]
28. Natural history of Fabry disease in females in the Fabry Outcome Survey.
Deegan PB; Baehner AF; Barba Romero MA; Hughes DA; Kampmann C; Beck M;
J Med Genet; 2006 Apr; 43(4):347-52. PubMed ID: 16227523
[TBL] [Abstract][Full Text] [Related]
29. The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels.
Vedder AC; Linthorst GE; van Breemen MJ; Groener JE; Bemelman FJ; Strijland A; Mannens MM; Aerts JM; Hollak CE
J Inherit Metab Dis; 2007 Feb; 30(1):68-78. PubMed ID: 17206462
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients.
Baptista MV; Ferreira S; Pinho-E-Melo T; Carvalho M; Cruz VT; Carmona C; Silva FA; Tuna A; Rodrigues M; Ferreira C; Pinto AA; Leitão A; Gabriel JP; Calado S; Oliveira JP; Ferro JM;
Stroke; 2010 Mar; 41(3):431-6. PubMed ID: 20110537
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.
Rolfs A; Böttcher T; Zschiesche M; Morris P; Winchester B; Bauer P; Walter U; Mix E; Löhr M; Harzer K; Strauss U; Pahnke J; Grossmann A; Benecke R
Lancet; 2005 Nov; 366(9499):1794-6. PubMed ID: 16298216
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of lymphedema among Anderson-Fabry disease patients: A report from the Fabry registry.
Alkhatib D; Vega JA; Pour-Ghaz I; Al-Taweel O; Khan S; DeCarr K; Bath A; Rawal A; Wilbanks D; Raja J; Butt A; Yedlapati N; Hopkin RJ; Jefferies JL
Mol Genet Metab; 2023 Apr; 138(4):107538. PubMed ID: 36812723
[TBL] [Abstract][Full Text] [Related]
33. Cervical artery dissection in young adults in the stroke in young Fabry patients (sifap1) study.
von Sarnowski B; Schminke U; Grittner U; Fazekas F; Tanislav C; Kaps M; Tatlisumak T; Putaala J; Haeusler KG; Borges do Amaral E Silva AD; Kinsella JA; McCabe DJ; Tobin WO; Huber R; Willeit J; Furtner M; Bodechtel U; Rolfs A; Kessler C; Hennerici MG
Cerebrovasc Dis; 2015; 39(2):110-21. PubMed ID: 25634656
[TBL] [Abstract][Full Text] [Related]
34. An intronic haplotype in α galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke.
Zeevi DA; Hakam-Spector E; Herskovitz Y; Beeri R; Elstein D; Altarescu G
Gene; 2014 Oct; 549(2):275-9. PubMed ID: 25101867
[TBL] [Abstract][Full Text] [Related]
35. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T
J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
Talbot AS; Lewis NT; Nicholls KM
Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
[TBL] [Abstract][Full Text] [Related]
37. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.
Waldek S; Patel MR; Banikazemi M; Lemay R; Lee P
Genet Med; 2009 Nov; 11(11):790-6. PubMed ID: 19745746
[TBL] [Abstract][Full Text] [Related]
38. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.
Schiffmann R; Warnock DG; Banikazemi M; Bultas J; Linthorst GE; Packman S; Sorensen SA; Wilcox WR; Desnick RJ
Nephrol Dial Transplant; 2009 Jul; 24(7):2102-11. PubMed ID: 19218538
[TBL] [Abstract][Full Text] [Related]
39. Screening for Fabry's disease in young patients with ischemic stroke in a Chinese population.
Song X; Xue S; Zhao J; Wu J
Int J Neurosci; 2017 Apr; 127(4):350-355. PubMed ID: 26981927
[TBL] [Abstract][Full Text] [Related]
40. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
